Quest Unveils New Advanced Alzheimer’s Diagnostic Test

Innovation

A new test aids in assessment of cognitive impairment that may be associated with Alzheimer’s disease in symptomatic patients.

Quest Genetic Counselors Bring Insight to Genetic Testing

Insights

Quest Diagnostics employs more than 30 genetic counselors who are board certified by the American Board of Genetic Counseling.

Chairman, President and CEO Steve Rusckowski participates in a health care discussion at the 2017 World Economic Forum Annual Meeting

Diagnostics & Health Care at the World Economic Forum

Insights

Quest Diagnostics CEO Steve Rusckowski participates in the WEF healthcare discussions

NY Giants Mark Herzlich Uses Lab Testing to Achieve Excellence

Insights

Heading into the playoffs the linebacker uses Blueprint for Athletes to gain insights.

Quest CEO Discusses Future Path with Modern Healthcare

Insights

Steve Rusckowski discusses the company’s goals and future and more in a Q&A with Modern Healthcare.

Quest Rings NYSE Closing Bell

Insights

In advance of our 20th anniversary of being listed on the New York Stock Exchange and our 50th anniversary as a company, on November 14, Quest Diagnostics President and CEO Steve Rusckowski was joined in New York by employees from around the country to ring the closing bell. Along with the 4 p.m. ceremony that […]

Quest Discusses Accelerating Growth, Operational Excellence with Investors

Insights

Members of the Quest Diagnostics senior management team present the company’s new two-point strategy to analysts and investors.

The Future of Precision Medicine Begins Today

Innovation

IBM Watson Genomics from Quest Diagnostics combines genomic sequencing expertise with Watson-powered cognitive computing to inform precision treatment and clinical trial options for cancer patients.